跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
GEMCITABINE-TEVA CONCENTRATE FOR SOLUTION FOR INFUSION 40MG/ML - HSA Drug Approval Details
Approvals
/
HSA
/
GEMCITABINE-TEVA CONCENTRATE FOR SOLUTION FOR INFUSION 40MG/ML
Approved
THERAPEUTIC
GEMCITABINE-TEVA CONCENTRATE FOR SOLUTION FOR INFUSION 40MG/ML
Pharmachemie B.V. (NETHERLANDS)
🇸🇬 Health Sciences Authority
Approval Date
May 13, 2026
Approval ID
8232fc5c2cb43687
Company
Pharmachemie B.V. (NETHERLANDS)
Type
Therapeutic
Approval Details
Approval Id
8232fc5c2cb43687
Drug Name
GEMCITABINE-TEVA CONCENTRATE FOR SOLUTION FOR INFUSION 40MG/ML
Product Name
GEMCITABINE-TEVA CONCENTRATE FOR SOLUTION FOR INFUSION 40MG/ML
Approval Number
SIN17538P
Approval Date
2026-05-13
Registrant
TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
INFUSION, SOLUTION CONCENTRATE
Route Of Administration
INTRAVENOUS
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
May 13, 2026
Approval ID
8232fc5c2cb43687
Type
Therapeutic
Back to HSA Approvals
